TG THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tg Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • Tg Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.8M, a 28.3% increase year-over-year.
  • Tg Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $40M.
  • Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $37.9M, a 97.4% increase from 2022.
  • Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.2M, a 68.7% decline from 2021.
  • Tg Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $61.3M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $37.9M +$18.7M +97.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $19.2M -$42.1M -68.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $61.3M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2019 $11.3M -$1.55M -12% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-02
2018 $12.9M -$3.06M -19.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $15.9M +$8.44M +112% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $7.51M -$8.19M -52.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $15.7M -$5.41M -25.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-16
2014 $21.1M +$15.9M +306% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $5.2M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.